| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Texas Visiting Nurse Service is a Harlingen, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
JAXJOX is a global fitness company revolutionizing the health and wellness industry through technology-enabled, connected at-home exercise equipment.
JBN Scientifica Inc is a Mendham, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Osler Health is on the vanguard of medical providers making the transition from being service providers to clinical managers. That means we are also responsible for the totality of each patients care. Osler Health is committed to providing the right care, at the right time, and, at the right cost to deliver the best results. That is why we do not partner with hospitals so that we are rewarded for your good health, not when you lose it. Osler is ranked in the top 10% nationally for quality, and 100% of our practices use advanced technology. Osler patients are also 112% healthier relative to peer groups. Our Mission – To improve the health status of each patient efficiently, effectively and with the highest quality care. Our Vision – To transform healthcare from a Managing Sickness model to a Preserving Wellness model.